Federico Bussolino

28.0k total citations · 6 hit papers
343 papers, 22.1k citations indexed

About

Federico Bussolino is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Federico Bussolino has authored 343 papers receiving a total of 22.1k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Molecular Biology, 63 papers in Immunology and 62 papers in Immunology and Allergy. Recurrent topics in Federico Bussolino's work include Angiogenesis and VEGF in Cancer (84 papers), Cell Adhesion Molecules Research (59 papers) and Axon Guidance and Neuronal Signaling (32 papers). Federico Bussolino is often cited by papers focused on Angiogenesis and VEGF in Cancer (84 papers), Cell Adhesion Molecules Research (59 papers) and Axon Guidance and Neuronal Signaling (32 papers). Federico Bussolino collaborates with scholars based in Italy, United States and Germany. Federico Bussolino's co-authors include Giovanni Camussi, Alberto Mantovani, Guido Serini, Ciro Tetta, Massimo Aglietta, Elisabetta Dejana, Luca Primo, Donatella Valdembri, Corrado Baglioni and F Sanavio and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Physical Review Letters.

In The Last Decade

Federico Bussolino

335 papers receiving 21.5k citations

Hit Papers

Hepatocyte growth factor is a potent angiogenic factor wh... 1989 2026 2001 2013 1992 1997 2002 1992 1989 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Bussolino Italy 74 9.9k 4.4k 4.2k 2.6k 2.4k 343 22.1k
William J. Henzel United States 63 16.3k 1.6× 6.4k 1.4× 4.2k 1.0× 4.3k 1.6× 1.6k 0.7× 117 28.6k
Donald M. McDonald United States 86 15.1k 1.5× 3.6k 0.8× 7.7k 1.9× 4.5k 1.7× 2.1k 0.8× 257 29.9k
Emilio Hirsch Italy 73 9.6k 1.0× 5.4k 1.2× 2.9k 0.7× 1.5k 0.6× 1.8k 0.7× 297 19.0k
John H. Kehrl United States 78 10.8k 1.1× 7.9k 1.8× 3.1k 0.7× 1.9k 0.7× 1.4k 0.6× 232 23.2k
Roy A. Black United States 50 7.3k 0.7× 3.9k 0.9× 3.8k 0.9× 2.6k 1.0× 2.7k 1.1× 95 14.8k
Toshio Kitamura Japan 76 10.2k 1.0× 9.4k 2.1× 5.1k 1.2× 2.0k 0.8× 1.0k 0.4× 349 23.3k
Vikas P. Sukhatme United States 92 16.6k 1.7× 5.9k 1.3× 4.1k 1.0× 6.0k 2.3× 1.4k 0.6× 249 32.8k
George Kollias Greece 89 12.1k 1.2× 10.9k 2.5× 5.6k 1.3× 3.5k 1.3× 1.2k 0.5× 306 30.3k
Towia A. Libermann United States 72 13.2k 1.3× 5.3k 1.2× 7.1k 1.7× 4.0k 1.5× 944 0.4× 270 28.0k
Fumimaro Takaku Japan 68 8.8k 0.9× 4.3k 1.0× 3.3k 0.8× 1.4k 0.5× 915 0.4× 657 20.9k

Countries citing papers authored by Federico Bussolino

Since Specialization
Citations

This map shows the geographic impact of Federico Bussolino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Bussolino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Bussolino more than expected).

Fields of papers citing papers by Federico Bussolino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Bussolino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Bussolino. The network helps show where Federico Bussolino may publish in the future.

Co-authorship network of co-authors of Federico Bussolino

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Bussolino. A scholar is included among the top collaborators of Federico Bussolino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Bussolino. Federico Bussolino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freddi, Stefano, Rosa Pennisi, Simona Fontana, et al.. (2025). TBC1D22B Regulates ER‐to‐Golgi Trafficking via RAB1B Inactivation and Promotes Oncogenic Programs in Breast Cancer. Advanced Science. 12(43). e02269–e02269.
2.
Bartolini, Alice, Daniela Cantarella, Annamaria Gullà, et al.. (2024). Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma Model. International Journal of Molecular Sciences. 25(20). 11228–11228.
3.
Bironzo, Paolo, Luca Primo, Silvia Novello, et al.. (2022). Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response. Clinical Lung Cancer. 23(6). e347–e352. 7 indexed citations
4.
Qiu, Yaqi, Federica Maione, Claudia Meda, et al.. (2020). HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction. Molecular Cancer Therapeutics. 19(12). 2476–2489. 10 indexed citations
5.
Doronzo, Gabriella, Elena Astanina, Davide Corà, et al.. (2018). TFEB controls vascular development by regulating the proliferation of endothelial cells. The EMBO Journal. 38(3). 62 indexed citations
6.
Gagliardi, Paolo Armando, Alberto Puliafito, Giulia Chiaverina, et al.. (2017). MRCKα is activated by caspase cleavage to assemble an apical actin ring for epithelial cell extrusion. The Journal of Cell Biology. 217(1). 231–249. 23 indexed citations
7.
Riganti, Chiara, Iris C. Salaroglio, Chiara Falcomatà, et al.. (2017). Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. OncoImmunology. 7(3). e1398874–e1398874. 34 indexed citations
8.
Bartolini, Alice, Simona Lamba, Daniele Oddo, et al.. (2016). BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer. Clinical Cancer Research. 22(19). 4923–4933. 51 indexed citations
9.
Bartolini, Alice, Daniela Di Paolo, Alessio Noghero, et al.. (2015). The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients. Cancer Research. 75(20). 4265–4271. 18 indexed citations
10.
Carrer, Alessandro, Silvia Moimas, Serena Zacchigna, et al.. (2012). Neuropilin-1 Identifies a Subset of Bone Marrow Gr1− Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth. Cancer Research. 72(24). 6371–6381. 43 indexed citations
11.
Maione, Federica, Lorena Zentilin, Mauro Giacca, et al.. (2012). Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. Journal of Clinical Investigation. 122(5). 1832–1848. 149 indexed citations
12.
Marchiò, Serena, Marco Soster, Andrea Muratore, et al.. (2012). A complex of α 6 integrin and E‐cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin‐like 6. EMBO Molecular Medicine. 4(11). 1156–1175. 39 indexed citations
13.
Noghero, Alessio, Alessia Perino, Giorgio Seano, et al.. (2012). Liver X Receptor Activation Reduces Angiogenesis by Impairing Lipid Raft Localization and Signaling of Vascular Endothelial Growth Factor Receptor-2. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2280–2288. 62 indexed citations
14.
Primo, Luca, Giorgio Seano, Cristina Roca, et al.. (2010). Increased Expression of α6 Integrin in Endothelial Cells Unveils a Proangiogenic Role for Basement Membrane. Cancer Research. 70(14). 5759–5769. 50 indexed citations
15.
Chirivi, Renato G.S., Giulia Taraboletti, Maria Rosa Bani, et al.. (1999). Human Immunodeficiency Virus-1 (HIV-1)-Tat Protein Promotes Migration of Acquired Immunodeficiency Syndrome–Related Lymphoma Cells and Enhances Their Adhesion to Endothelial Cells. Blood. 94(5). 1747–1754. 25 indexed citations
16.
Follenzi, Antonia, et al.. (1995). In Vivo Activation of met Tyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes Angiogenesis. Arteriosclerosis Thrombosis and Vascular Biology. 4 indexed citations
17.
Bussolino, Federico, Marco Arese, Giuseppe Montrucchio, et al.. (1995). Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.. Journal of Clinical Investigation. 96(2). 940–952. 90 indexed citations
18.
Tetta, Ciro, Giovanni Camussi, Federico Bussolino, Katharine Herrick‐Davis, & Corrado Baglioni. (1991). Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.. Journal of Pharmacology and Experimental Therapeutics. 257(2). 616–620. 20 indexed citations
19.
Ghigo, Dario, Maria Felice Brizzi, Gian Carlo Avanzi, et al.. (1990). Evidence for a role of the Na+/H+ exchanger in the colony‐stimulating‐factor‐induced ornithine decarboxylase activity and proliferation of the human cell line M‐07e. Journal of Cellular Physiology. 145(1). 147–154. 9 indexed citations
20.
Stratta, Piero, Caterina Canavese, Loredana Colla, et al.. (1987). Acute Renal Failure in Preeclampsia-Eclampsia. Gynecologic and Obstetric Investigation. 24(4). 225–231. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026